Trinity Biotech | TRIB - Current Assets

Stock Price
0.76
Daily Change
-0.06 -6.96%
Monthly
-0.21%
Yearly
-18.06%
Q1 Forecast
0.79

Trinity Biotech reported $35.52M in Current Assets for its fiscal quarter ending in September of 2025.





Current Assets Change Date
Abbott USD 24.84B 371M Sep/2025
Bayer EUR 32.88B 873M Sep/2025
Bio-Rad Laboratories USD 2.84B 30.9M Sep/2025
EDAP TMS EUR 51.48M 6.99M Jun/2025
J&J USD 54.61B 113M Sep/2025
Roche Holding CHF 38.73B 3.03B Dec/2025
Siemens EUR 64.71B 1.08B Sep/2025
Thermo Fisher Scientific USD 28.71B 6.41B Dec/2025
Tosoh JPY 731.01B 3.35B Sep/2025
Trinity Biotech USD 35.52M 2.52M Sep/2025
Veracyte USD 449.22M 34.54M Sep/2025